Doug Brunk

San Diego

Reporter for MDedge. Author of three books related to Kentucky basketball, most recently this one: https://t.co/cZ0Dt0NgjR

Articles

Qué pensar de las comorbilidades asociadas a la rosácea

2 months ago | espanol.medscape.com | Doug Brunk

close ¿Está seguro que quiere cerrar su sesión? A medida que un flujo constante de estudios señala asociaciones entre la rosácea y las comorbilidades, que van desde las enfermedades cardiovasculares hasta la depresión y los problemas digestivos, los pacientes pueden acudir a consulta dermatológica en busca de orientación sobre cómo interpretar estos hallazgos.
What Defines High-Risk SCC Is Not Always Clear-Cut

2 months ago | medscape.com | Doug Brunk

CORONADO, Calif. — Despite recent advances in the treatment of cutaneous squamous cell carcinoma (SCC), a lack of consensus remains on what defines high-risk disease, according to Travis W. Blalock, MD, MBA. “There’s a lot of variability in regard to what we believe to be higher-risk tumors,” Blalock, director of Dermatologic Surgery, Mohs Micrographic Surgery, and Cutaneous Oncology at Emory University School of Medicine, Atlanta, said at the annual Melanoma and Cutaneous Oncology Symposium.
Advances in Systemic Treatments for Melanoma Highlighted

2 months ago | medscape.com | Doug Brunk

CORONADO, Calif. — Advances in adjuvant and neoadjuvant systemic therapies are continuing to improve recurrence-free and distant metastasis-free survival rates in patients with advanced melanoma.
Expert Tips on Mohs Surgery for Melanoma

2 months ago | medscape.com | Doug Brunk

CORONADO, CALIF. — According to Christopher J. Arpey, MD, there is no single best approach to treating lentigo maligna (LM) and LM melanoma (LMM), but Mohs micrographic surgery is a sensible option in cases where margin size is critical and tissue conservation with precision is essential.
Study sheds light on pregnancy outcomes following ocrelizumab treatment

Jan 25, 2025 | mdedge.com | Doug Brunk

AT THE CMSC ANNUAL MEETING– Data from the ocrelizumab clinical development program gives clinicians a first look at pregnancy outcomes after exposure to the drug, but the small size limits the ability to draw firm conclusions. In the United States, prescribing information for ocrelizumab states that women of childbearing potential should use contraception while receiving ocrelizumab and for 6 months after the last infusion.
What to Make of the Comorbidities Linked to Rosacea

Jan 23, 2025 | medscape.com | Doug Brunk

As a steady stream of studies suggests associations between rosacea and comorbidities, ranging from cardiovascular disease to depression and gastrointestinal (GI) issues, patients may look to their dermatologists for guidance on how to interpret these findings.
New HS Guidelines Focus on Special Patient Populations

Jan 22, 2025 | medscape.com | Doug Brunk

When it comes to managing hidradenitis suppurativa (HS) in special patient populations, new guidelines rate the existing evidence as “strong” for the following clinical scenarios: The continued use of biologics by pregnant patients throughout pregnancy, the use of adalimumab by breastfeeding patients who require biologics, and the use of oral doxycycline by patients with a history of malignancy who require systemic antibiotics for treatment of HS.
Study Examines Acne Relapse and Isotretinoin Retrial

Jan 17, 2025 | medscape.com | Doug Brunk

Among patients treated with isotretinoin for acne, approximately one fifth experienced a relapse that required additional treatment with systemic medication, and 8.2% underwent a retrial with isotretinoin, in a cohort study that used national claims data.
Experts Weigh in

Jan 16, 2025 | medscape.com | Doug Brunk

While artificial intelligence (AI) is helping clinicians in medical dermatology improve diagnostic accuracy, streamline workflows, and develop patient treatment plans, its wide adoption for use in cosmetic dermatology is still in the early stages. According to Jeffrey Dover, MD, co-director of SkinCare Physicians in Chestnut Hill, Massachusetts, cosmetic dermatologists are primarily using AI for patient management in the same way as their counterparts in medical dermatology.
El ajolote promete revelar los secretos de la regeneración de la piel

Jan 14, 2025 | espanol.medscape.com | Doug Brunk

Durante más de 200 años, las y los investigadores han estado cautivados por las salamandras ajolote (Ambystoma mexicanum) y sus extraordinarias capacidades regenerativas, tratando de descubrir secretos que podrían revolucionar la medicina regenerativa, incluida la cicatrización de las heridas sin que queden cicatrices. "La salamandra ajolote es el animal más estudiado de la ciencia por su capacidad neoténica de regeneración", declaró en una entrevista la Dra. Jill S.